Day: January 7, 2025

Ipsen – December 2024 – Monthly information relative to the total number of voting rights and shares composing the share capital

Written by Customer Service on January 7, 2025. Posted in Public Companies.

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers) Market: Euronext Paris ISIN Code: FR 0010259150LEI: 549300M6SGDPB4Z94P11Date Total number of shares composing the share capital Total number of voting rights (1)31 December 2024 83,814,526 Gross total* of voting rights: 131,939,858Net total** of voting rights: 130,834,785(1) Existence of a statutory clause imposing an obligation to declare threshold crossing complementary to the one relative to the legal thresholds (Article 10). * Gross total = total number of voting rights attached to the total number of shares, including the number of shares which benefit...

SAFE GROUP – 16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires: presentation of Professor Maestretti’s clinical results on the Sycamore device

Written by Customer Service on January 7, 2025. Posted in Public Companies.

16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires: presentation of Professor Maestretti’s clinical results on the Sycamore device Fleurieux-sur-l’Arbresle – France – January 7, 2025 at 6pm. Safe announces that Professor Gianluca Maestretti, Head of Orthopaedics at the Freiburg Hospital, will present his clinical results on the Sycamore device at the 16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires, to be held in Nice on January 24, 2025. Professor Maestretti, a recognized expert in orthopaedic surgery, will share his clinical observations on the use of Sycamore, an innovative device for the minimally invasive treatment of vertebral fractures. This presentation will be followed by a discussion with a panel of experts in interventional radiology, highlighting...

Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2024

Written by Customer Service on January 7, 2025. Posted in Public Companies.

Strasbourg, January 7, 2025 – 06:00 pm CET Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2024, the following resources were managed through the liquidity account:359,661 shares € 80,653.30In the second half of 2024, a total of:Purchases 250,777 shares € 243,947.38 1,154 market transactionsSales 229 905 shares € 230,275.17 1,081 market transactionsIt is recalled that when the liquidity program was initially established in 2016, the following resources were made available:€ 500,000.00At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:164,183 shares € 246,158.00ContactsTransgene: Lucie LARGUIERCFO+33 (0)3 88 27 91 00investorrelations@transgene.fr Attachment...

Dassault Aviation: Deliveries, order intakes and backlog in number of new aircraft as of December 31, 2024

Written by Customer Service on January 7, 2025. Posted in Earnings Releases And Operating Results.

Dassault Aviation (consolidated figures) Deliveries, order intakes and backlog in number of new aircraft as of December 31, 2024(unaudited figures) AIRCRAFT DELIVERED IN 2024 21 Rafale (14 France, 7 Export) were delivered, while 20 had been guided, versus 13 Rafale (11 France, 2 Export) delivered in 2023. 31 Falcon were delivered, while 35 had been guided, versus 26 Falcon delivered in 2023. AIRCRAFT ORDERED IN 2024 30 Export Rafale were ordered versus 60 Rafale (42 France, 18 Export) in 2023. 26 Falcon were ordered versus 23 Falcon in 2023. AIRCRAFT IN BACKLOG As of December 31, 2024, the backlog includes:220 Rafale (164 Export, 56 France) versus 211 Rafale as of December 31, 2023, 79 Falcon versus 84 Falcon as of December 31, 2023.UPCOMING FINANCIAL RELEASE Dassault Aviation will publish its full annual results on March 5, 2025,...

Mohawk Industries, Inc. Invites You to Join its Fourth Quarter Earnings Conference Call

Written by Customer Service on January 7, 2025. Posted in Public Companies.

CALHOUN, Ga., Jan. 07, 2025 (GLOBE NEWSWIRE) — In conjunction with Mohawk Industries’ (NYSE: MHK) fourth quarter 2024 earnings release on Thursday, February 6, you are invited to listen to the conference call that will be broadcast live on Friday, February 7, at 11:00 am ET.What: Mohawk Industries’ Fourth Quarter Earnings Call When: February 7, 2025 11:00 am ET Where: www.mohawkind.com Select “Investors” tab How: Live over the Internet – Simply log on via the web at the address above or Register for the conference call at: https://dpregister.com/sreg/10195645/fe39dbe57e Live Conference Call: Dial 1-833-630-1962 (U.S./Canada) Dial 1-412-317-1843 (International) For those unable to listen at the designated time, the call will remain...

Roche Vabysmo Sales Surpassed USD 4 Billion In 2024

Written by Customer Service on January 7, 2025. Posted in Mergers And Acquisitions.

Vabysmo Sales Accounts For More Than 35% Of Global Bispecific Antibodies Market Says Kuick Research Delhi, Jan. 07, 2025 (GLOBE NEWSWIRE) — Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights:Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2024) Global Bispecific Antibodies Market Size 2024: > USD 8.5 Billion Global Bispecific Antibodies Market Forecast Till 2029 Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2024) Approved Bispecific Antibodies Regional Sales (2018 till 2024) Clinical and Commercial Insight On Approved Bispecific Antibodies: 16 Antibodies Approved Bispecific Antibodies Pricing and Dosage Analysis Global Bispecific Antibodies...

UniFirst Confirms Rejection of Unsolicited, Non-Binding and Highly Conditional Acquisition Proposal from Cintas Corporation

Written by Customer Service on January 7, 2025. Posted in Mergers And Acquisitions.

WILMINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (“UniFirst” or the “Company”) today confirmed that in November and December 2024, its Board of Directors received and unanimously rejected an unsolicited, non-binding and highly conditional proposal from Cintas Corporation to acquire all outstanding common and Class B shares of UniFirst for $275.00 per share. Consistent with its fiduciary duties and in consultation with its independent advisors, the Board conducted a careful review of the unsolicited proposal and determined that it is not in the best interests of UniFirst, its shareholders and other stakeholders. In making its determination, the Board considered the offer price, execution and business risks, feedback from some of the Company’s largest shareholders by voting power, and the Company’s...

FLUENT Unveils Bag-O: A New Value Brand for Florida Medical Marijuana Patients, Launching January 7

Written by Customer Service on January 7, 2025. Posted in Public Companies.

All Flower Products Launching Exclusively in 14-Gram Bags TAMPA, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) — Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically integrated, multi-state cannabis company operating under the FLUENT™ brand, today announces the launch of Bag-O, a new value-focused line of premium cannabis flower, available to Florida medical marijuana patients starting January 7. With an emphasis on quality and affordability, Bag-O offers patients access to cannabis at competitive prices, expanding FLUENT’s product offerings and reinforcing its commitment to accessibility. “Bag-O was developed in direct response to patient feedback, addressing the growing demand for larger quantities of high-quality cannabis at an affordable price point,” said Robert Beasley, CEO of FLUENT. “Thanks...

Freddie Mac Appoints James Whitlinger Chief Financial Officer

Written by Customer Service on January 7, 2025. Posted in Public Companies.

Ten-year company veteran named EVP & CFO effective immediately MCLEAN, Va., Jan. 07, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today announced the appointment of James Whitlinger as executive vice president and chief financial officer (CFO), effective January 1, 2025. Whitlinger previously served as the company’s senior vice president and Single-Family CFO since 2014. He has served as interim CFO since June of 2024, following the departure of Christian Lown, who served as CFO from June of 2020 to June 2024. “It’s with great pleasure that we announce Jim Whitlinger as the company’s new chief financial officer,” said Diana Reid, Chief Executive Officer of Freddie Mac. “Jim is a proven leader with more than 30 years of financial management and accounting experience. As a 10-year veteran of Freddie Mac, he is well positioned...

West Red Lake Gold Announces Positive Pre-Feasibility Study Results for Madsen Gold Mine with $315M After-Tax NPV and $70M Average Annual Free Cash Flow

Written by Customer Service on January 7, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, Jan. 07, 2025 (GLOBE NEWSWIRE) — West Red Lake Gold Mines Ltd. (“West Red Lake Gold” or the “Company”) (TSXV: WRLG) (OTCQB: WRLGF) is pleased to announce the results of the pre-feasibility study (“PFS”) prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”) for the imminent restart of its 100% owned Madsen Mine project in the Red Lake Gold District of northwestern Ontario, Canada. West Red Lake Gold will hold a conference call on January 8th at 11:00am ET, followed by a question-and-answer period. To access the call, please register here: https://www.amvestcapital.com/webinar-directory/westredlakegoldmines010825. The webinar will be archived for viewing at www.westredlakegold.com All dollar amounts in this news release are in Canadian dollars...

Day: January 7, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice